What is Bone Mineral Density?
Bone mineral density (BMD) quantifies the amount of mineral (mostly calcium and phosphate) packed into a specific volume of bone. It reflects bone strength and is a key indicator for diagnosing osteoporosis, assessing fracture risk, and monitoring the effects of therapy.
BMD is expressed in two common units:
- g/cm (grams per square centimetre) the amount of mineral per projected area.
- Tscore the number of standard deviations a persons BMD deviates from the average young adult (peak) reference.
- Zscore the deviation from an agematched population.
How is BMD Measured?
The most widely used technique is dualenergy Xray absorptiometry (DXA). It is quick, lowdose, and can assess the lumbar spine, hip, and sometimes the forearm.
| Method | Typical Site | Advantages | Limitations |
|---|---|---|---|
| DXA | Lumbar spine, hip, forearm | High precision, low radiation | Cannot detect microarchitectural changes |
| Quantitative CT (QCT) | Spine, hip | 3D data, separates cortical & trabecular bone | Higher radiation, more expensive |
| Quantitative Ultrasound (QUS) | Calcaneus (heel) | No radiation, portable | Less predictive for hip fractures |
| Peripheral DXA (pDXA) | Forearm, heel | Small, inexpensive | Limited clinical validation |
Results are interpreted using the World Health Organization (WHO) criteria:
- Normal: Tscore 1.0
- Osteopenia (low bone mass): 1.0>Tscore>2.5
- Osteoporosis: Tscore 2.5
- Severe osteoporosis: Tscore 2.5 with one or more fragility fractures
Risk Factors for Low BMD
Nonmodifiable
- Age bone loss accelerates after age 30 in women and 40 in men.
- Sex women have lower peak bone mass and experience rapid loss after menopause.
- Genetics family history of osteoporosis or fractures.
- Ethnicity Caucasian and Asian individuals are at higher risk compared with AfricanAmerican or Hispanic groups.
Modifiable
- Low calcium or vitaminD intake.
- Physical inactivity, especially lack of weightbearing exercise.
- Smoking and excessive alcohol consumption.
- Corticosteroid or other boneaffecting medication use.
- Chronic diseases e.g., rheumatoid arthritis, hyperthyroidism, chronic kidney disease.
Conditions Associated with Abnormal BMD
While osteoporosis is the most recognized, several other disorders influence bone density:
- Osteopenia: early stage of bone loss, often reversible with lifestyle changes.
- Secondary osteoporosis: caused by endocrine disorders (hyperparathyroidism, Cushings syndrome), gastrointestinal malabsorption, or certain medications.
- Pagets disease: abnormal bone remodeling leading to enlarged but weak bones.
- Osteogenesis imperfecta: genetic collagen defect resulting in fragile bones.
Lifestyle & Nutrition for Healthy Bones
Calcium
Adults 1950 years: 1,000mg/day; women >50 and men >70: 1,200mg/day.
VitaminD
Essential for calcium absorption. Recommended 600800IU/day; higher doses (1,0002,000IU) may be needed for deficient individuals.
Physical Activity
Weightbearing and resistance exercises (walking, jogging, resistance bands, weight lifting) stimulate bone formation. Aim for 150minutes of moderate activity weekly.
Other Nutrients
- Magnesium, potassium, and vitaminK2 support mineralization.
- Protein intake of 1.01.2g/kg body weight maintains bone matrix.
Habits to Avoid
- Smoking nicotine interferes with osteoblast function.
- Alcohol >3 drinks/day reduces bone formation.
Treatment Options for Low BMD
Pharmacologic Therapy
- Bisphosphonates (e.g., alendronate, risedronate): inhibit osteoclastmediated bone resorption.
- Denosumab: monoclonal antibody that reduces RANKL activity, decreasing resorption.
- Selective estrogen receptor modulators (SERMs): mimic estrogens protective effect on bone.
- Parathyroid hormone analogs (teriparatide, abaloparatide): stimulate new bone formation.
- Romosozumab: sclerostin inhibitor that both builds bone and reduces resorption.
When Medication Is Not Indicated
Patients with osteopenia but no major risk factors may be managed with lifestyle modification and periodic monitoring.
Monitoring
DXA scans are usually repeated every 12years to assess treatment efficacy. Changes of 3% in lumbar spine or hip BMD are considered clinically meaningful.
Key Takeaways
- BMD provides a snapshot of bone strength and fracture risk.
- DXA remains the gold standard for diagnosis and monitoring.
- Both genetics and modifiable lifestyle factors shape bone health.
- Adequate calcium, vitaminD, regular weightbearing activity, and avoiding tobacco/alcohol are foundational.
- Pharmacologic therapy is reserved for osteoporosis or highrisk osteopenia, guided by Tscore and clinical judgement.
